Related content

Immunotherapy of MHC class I-deficient tumors

By Reiniš Milan  

Future Oncology, Vol. 6, Iss. 10, 2010-10 ,pp. : 1577-1589

Future Medicine

Access to resources Recommend Favorite

Clinical significance of the immunostimulatory MHC class I chain-related molecule A and NKG2D receptor on NK cells in pancreatic cancer

By Duan Xiaohui  

Medical Oncology, Vol. 28, Iss. 2, 2011-06 ,pp. : 466-474

Humana Press, Inc

Access to resources Recommend Favorite

Expression of MHC I and NK ligands on human CD133 + glioma cells: possible targets of immunotherapy

By Wu Anhua   Wiesner Steve   Xiao Jing   Ericson Katya   Chen Wei   Hall Walter   Low Walter   Ohlfest John  

Journal of Neuro-Oncology, Vol. 83, Iss. 2, 2007-06 ,pp. : 133-133

Springer Publishing Company

Access to resources Recommend Favorite

Expression of MHC I and NK ligands on human CD133⁺ glioma cells: possible targets of immunotherapy

By Wu Anhua   Wiesner Steve   Xiao Jing   Ericson Katya   Chen Wei   Hall Walter   Low Walter   Ohlfest John  

Journal of Neuro-Oncology, Vol. 83, Iss. 2, 2007-06 ,pp. : 121-131

Springer Publishing Company

Access to resources Recommend Favorite

Induction of protective immune responses against NXS2 neuroblastoma challenge in mice by immunotherapy with GD2 mimotope vaccine and IL-15 and IL-21 gene delivery

By Kowalczyk Aleksandra   Wierzbicki Andrzej   Gil Margaret   Bambach Barbara   Kaneko Yutaro   Rokita Hanna   Repasky Elizabeth   Fenstermaker Robert   Brecher Martin   Ciesielski Michael   Kozbor Danuta  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 9, 2007-09 ,pp. : 1443-1458

Springer Publishing Company

Access to resources Recommend Favorite